Originally published In Press as doi:10.1074/jbc.M102561200 on May 29, 2001
J. Biol. Chem., Vol. 276, Issue 31, 28829-28834, August 3, 2001
Conformational Change in the Vinculin C-terminal Depends on a
Critical Histidine Residue (His-906)*
Gregory J.
Miller and
Eric H.
Ball
From the Department of Biochemistry, University of Western Ontario,
London, Ontario N6A 5C1, Canada
Received for publication, March 21, 2001
 |
ABSTRACT |
A phospholipid-controlled interaction between the
N-terminal and C-terminal domains of vinculin is thought to be a major
mechanism that regulates binding activities of the protein. To probe
the mechanisms underlying these interactions we used chemical
modification and site-directed mutagenesis directed at histidine
residues. Diethylpyrocarbonate (DEPC) modification of the
C-terminal, but not the N-terminal, domain greatly decreased affinity
of the N-terminal-C-terminal binding, implicating histidine residues in
the C-terminal. Mutation of either or both C-terminal histidines (at
positions 906 and 1026), however, did not affect N-C binding at neutral
pH. The H906A mutation did prevent DEPC effects and also prevented the normal decrease in binding affinity for the N-terminal at lower pH. We
found that the wild type C-terminal domain, but not the H906A mutant,
underwent a conformational change at pH 6.5, reflected in an altered
circular dichroism spectrum and apparent oligomerization. Phospholipid
also induced conformational changes in the wild type C-terminal domain
but not in the H906A mutant, even though the mutant protein did bind to
the phospholipid. Finally, the sensitivity of the N-C interaction to
phospholipid was much reduced by the H906A mutation. These results show
that H906 plays a key role in the conformational dynamics of the
C-terminal domain and thus the regulation of vinculin.
 |
INTRODUCTION |
Vinculin is a cytoskeletal protein involved in the attachment of
the actin cytoskeleton to the plasma membrane at some types of cell
junctions (1). Although the precise role of vinculin within adhesions
is not clear, it is critical for mammalian development (2) and is
highly conserved from nematode to human (3). It is a multidomain
protein with a 90-kDa globular head and a 30-kDa tail connected by a
proline-rich domain (4). Each of these domains has been shown to have
binding sites for several other proteins (e.g. talin,
vasodilator-stimulated phosphoprotein, actin), and thus vinculin
may function as an integrator or sensor (reviewed in Refs. 5-8). In
cells vinculin is found in soluble form as well as bound in the dense
assemblies of proteins at adhesion sites (9). Its incorporation into
adhesion sites has been shown to be dependent upon its interaction with
other proteins (10), and it is thought that interactions between its N-
and C-terminal domains control its binding proclivities (11-14). Thus
the observed tight association of the N-terminal head and C-terminal
tail domains within the soluble protein acts to mask binding sites for
several adhesion and signaling proteins.
This self-association has been shown to
be decreased by PIP21 (15, 16), implicating
this lipid in the regulation of vinculin location and activity.
The interaction between the N- and C-terminal domains is of
great interest because it is key to understanding vinculin regulation. The interacting regions of the domains have been mapped to small oppositely charged sequences (15, 17), but how binding might be turned
on and off is not known. Conformational changes in the C-terminal
domain have been detected by alterations in limited proteolysis
patterns or cross-linking (18, 19), suggesting that the domain
undergoes structural rearrangements in response to lipids or upon actin
binding. Circular dichroism spectroscopy also points to conformational
changes in the domains upon binding to each other (17). Despite the
recent determination of the three-dimensional structure of the
C-terminal domain showing a mainly
-helical bundle (19), the nature
of such conformational changes is not clear. Because lipid binding
sites have been mapped to the C-terminal (20-22), it may be changes in
this domain that result in vinculin activation by altering the binding
site for the N-terminal domain. In this model dissociation of the
N-terminal would then expose binding sites in both domains, but further
evidence is necessary to clarify the events.
A few observations point to a key role for histidine residues in
the N-terminal-C-terminal interaction. First, proteolytic cleavage of
native vinculin left the head and tail regions of the molecule still
tightly associated, but they could be separated at lower pH (pH 5)
(23). Our own work has shown a pH-sensitive interaction between the
expressed N-terminal (amino acids 1-266) and C-terminal (amino acids
877-1066) domains, with half-maximal inhibition occurring between pH 6 and 7 (17). Second, truncation of the last 15 residues from the
C-terminal domain left a molecule that could not bind lipid at neutral
pH but could do so at pH 5.5 (19). Thus at least two properties of
vinculin change in the pH range where histidine side chains become
protonated. Third, there are several highly conserved histidine
residues in both the N- and C-terminal domains.
With the aim of understanding vinculin regulation, we have previously
expressed in bacteria and characterized the two terminal domains of the
molecule (17). Here we report studies investigating the potential role
of histidine residues in the interaction between them. Evidence gleaned
from chemical modification and mutagenesis of two histidines in the
C-terminal implicates histidine 906 as a key player in conformational
changes that affect lipid binding and oligomerization as well as
interdomain binding. This points to ionic interactions as a driving
force in C-terminal conformational flexibility.
 |
EXPERIMENTAL PROCEDURES |
Recombinant Proteins--
Recombinant DNA techniques were from
Sambrook et al. (24). Vinculin constructs V-(1-266) and
V-(877-1066) were cloned, expressed, and purified as described
(17).
Site-directed mutagenesis of His-906 and His-1026 to alanine was
performed using a polymerase chain reaction protocol (25). The
mutagenic primers used were CAGACAGCTGGCTGATGAAGC for H906A and
GATGCTGGTGGCCAATGCCCA for H1026A. The resulting polymerase chain
reaction products were cloned, sequenced, and placed in pGEX-KG (26).
To make the double H906A,H1026A mutant, restriction fragments
containing the individual mutations were ligated together. Proteins
were induced, isolated, and cleaved from their glutathione S-transferase partner as described (17).
Chemical Modification of Histidine Residues--
Vinculin
domains V-(1-266) and V-(877-1066) (25 µM) were reacted
with DEPC (0.5 mM) in 20 mM MES, pH 6.5, 75 mM NaCl, pH 7.0, at 20 °C for 10, 30, and 60 min prior
to quenching with 2 mM imidazole. Following dialysis to
remove unreacted DEPC, the number of modified residues was determined
by measuring the increase in absorbance at 240 nm (
= 3200 M
1) (27). There was no significant difference
in the degree of DEPC modification between the 10- and 60-min reactions.
Circular Dichroism--
The far-UV spectra of vinculin domains
were measured using a Jasco-J810 spectropolarimeter. Solutions
contained 2.5 µM V-(877-1066), V-(877-1066/H906A),
V-(877-1066/H1026A), or V-(877-1066/H906A+H1026A) in 20 mM MES, pH 7.0, 25 mM NaCl, 3 mM
MgCl2, and 1 mM EGTA. Spectra were measured
between 190 and 260 nm.
The effect of PI on the spectra of each construct was determined.
Solutions contained 2.5 µM V-(877-1066),
V-(877-1066/H906A), V-(877-1066/H1026A), or
V-(877-1066/H906A+H1026A) and 100 µM PI. PI in buffer
alone did not give measurable spectra within the 190-260 nm range.
Determination of the
-helical content of the constructs was
determined using the CDNN deconvolution program (28).
Solid-phase Protein-binding Assay--
Protein-protein
interactions were measured using a solid-phase binding assay as
described (17). Binding was performed in 20 mM MES, pH 7.0, 50 mM NaCl, 3 mM MgCl2, 1 mM EGTA.
The activity of the DEPC-modified domains was determined by competition
assay. V-(877-1066) was coated on the wells of a 96-well plate, and
binding of 125I-labeled V-(1-266) was determined in the
presence of the DEPC-modified proteins.
The Ki of DEPC-modified protein and PI inhibition of
the interaction between V-(1-266) and V-(877-1066) or
V-(877-1066/H906A) was calculated using the Cheng-Prusoff equation
(29): Ki = IC50/(1 + (125I-labeled V-(1-266)/Kd).
The effect of phospholipids on protein adsorbed to the 96-well plates
was determined by coating wells with unlabeled protein at 15 µg/ml
and 125I-labeled protein at trace concentrations for 2 h. Wells were then blocked with 3% bovine serum albumin in
Tris-buffered saline for 2 h. Phospholipids were then added at
1000 µM in 100 µl of buffer for 10 h. After
washing, the amount of labeled protein remaining on the plate was not
significantly different from control wells incubated for 10 h with
buffer alone.
Size Exclusion Gel Filtration Chromatography--
Size exclusion
chromatography of the various proteins was performed using a 24-ml
Superose 12 HR column (Amersham Pharmacia Biotech). Samples of 25 µg
were run at 0.5 ml/min in 10 mM Tris-HCl, pH 7.5, 75 mM NaCl, 1 mM EDTA, and 1 mM dithiothreitol.
A sample of each fraction was run on an SDS-polyacrylamide gel (15%),
and the intensity of the band was measured using densitometry (Alpha
InnoTech Corp.). Data were plotted as the percentage of the total
protein eluting from the column measured in each fraction.
Phospholipid Binding Assay--
PI (Doosan-Serdary Research
Laboratories, Englewood Cliffs, NJ) was dissolved at 10 mg/ml in
chloroform. PI was dried down from a chloroform stock under nitrogen
gas and suspended in 20 mM MES, pH 6.8, 1 mM
EGTA, and 75 mM NaCl. The lipid suspension was sonicated
(5 × 2 min) on ice.
Vinculin domains were labeled using IODO-GEN (Pierce, Brockville,
Ontario) as described (30), and lipid binding was assayed using a gel
filtration column. Protein samples were incubated with PI
vesicles for 30 min at room temperature before 100-µl samples were
loaded onto Ultrogel AcA 34 columns (8 × 0.5 cm) (LKB,
Bromma, Sweden). Binding was performed in 20 mM MES buffer, pH 6.8, 75 mM NaCl, 3 mM MgCl2, 1 mM EGTA. Fractions were collected in 200-µl aliquots.
Each fraction was counted in a Wallac model 1470
-counter. Elution
patterns of each protein were determined in the presence and absence of
phospholipid. Phospholipid content in each fraction was measured using
a detergent-dye solubilization assay as described (31).
 |
RESULTS |
Effect of DEPC Modifications on V-(1-266)-V-(877-1066)
Binding--
To directly probe for the role of histidine residues in
the N-C domain interaction, each domain was treated separately with DEPC, which reacts specifically with histidine residues to produce carbethoxyhistidine. The extent of reactions was quantified by measuring the increase in absorbance of the modified peptides at 240 nm
(
= 3200 M
1) (27). Maximal modification
occurred within 10 min, and histidine residues in V-(1-266) were found
to be 48 ± 15% modified (2.4 ± 0.6 of 5 histidine
residues) whereas construct V-(877-1066) was found to be 90 ± 18% modified (>1.4 residues out of 2 modified).
The effect of this modification on the structures of the proteins was
examined using circular dichroism. For both V-(1-266) and
V-(877-1066) there were measurable differences in the determined secondary structure. The unmodified V-(1-266) was calculated to be
64%
-helical, which decreased to 59% after DEPC, whereas the V-(877-1066) was found to be 43% helical before and 37% after DEPC
treatment (data not shown).
Interaction of the modified domains was measured using a solid-phase
binding assay (Fig. 1). Unmodified
V-(877-1066) was coated on 96-well assay plates, and binding of
125I-labeled V-(1-266) was measured in the presence of
variable concentrations of DEPC-modified V-(1-266), V-(877-1066), or
the unmodified domains. The measured Ki values for
the modified proteins were 61 ± 14 nM for V-(1-266)
compared with 87 ± 20 nM for the unmodified construct
and 367 ± 45 nM for the modified V-(877-1066)
compared with 70 ± 15 nM for the unmodified
construct. These results provide strong evidence for the importance of
histidine(s) in the C-terminal domain.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Competitive assay of DEPC-modified vinculin
domains. Using a solid-phase binding assay, the ability of
DEPC-modified V-(1-266) and V-(877-1066) were tested for their
ability to compete with unlabeled domains in a binding reaction.
V-(877-1066) was coated on the wells of a 96-well plate, and binding
of 125I-labeled V-(1-266) was tested in the presence of
DEPC-modified ( ) or unmodified ( ) V-(1-266) (A) and
DEPC-modified ( ) or unmodified ( ) V-(877-1066)
(B).
|
|
Effect of Histidine Mutations on V-(877-1066) Activity and
Conformation--
Comparison of the vinculin sequences from four
different species and one meta-vinculin sequence shows that the two
histidines (His-906 and His-1026 from the human vinculin sequence) in
the tail domain are totally conserved although they are not found in
the related catenins. To examine the role of these histidines, three
mutant constructs were made, expressed, and purified: the single
mutants V-(877-1066/H906A) and V-(877-1066/H1026A), as well as the
double mutant V-(877-1966/H906A,H1026A), for comparison with the wild
type tail domain.
The effect of the histidine mutations on the ability of the tail
domains to bind to V-(1-266) was determined using a solid-phase binding assay. At pH 7.0, V-(877-1066) bound to V-(1-266) with a
Kd of 90 ± 30 nM, whereas the
mutants V-(877-1066/H906A), V-(877-1066/H1026A), and
V-(877-1066/H906A,H1026A) bound with Kd values of
110 ± 20, 80 ± 10, and 130 ± 30 nM,
respectively (Fig. 2A). Thus,
surprisingly, at pH 7.0, there was no significant difference between
the binding affinities of the wild type vinculin tail and the mutants.
Because the pK of histidine is near 6, we also checked lower
pH values. At pH 5.5 V-(877-1066) bound to V-(1-266) with a
Kd of 680 ± 110 nM showing a large
decrease in binding affinity but with no loss in total binding
capacity. This finding is consistent with the observation that low pH
allows separation of the vinculin head and tail (23). The mutant
proteins containing the His-906 mutation, however, did not show the
decreased affinity at lower pH (Fig. 2B). The mutant
C-terminal domains with the His-906, His-1026, or both mutations bound
to V-(1-266) with Kd values of 120 ± 30, 470 ± 80, and 210 ± 40 nM, respectively.
Therefore, the H906A mutation and not the H1026A seems to confer
resistance to the loss of affinity at pH 5.5.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Binding of V-(877-1066) and histidine
mutants to V-(1-266). Using a solid-phase binding assay, the
ability of V-(877-1066) ( ), V-(877-1066/H906A) ( ),
V-(877-1066/H1026A) ( ), and V-(877-1066/H906A, H1026A) ( ) to
bind V-(1-266) was tested. V-(1-266) or the mutants were coated on
the wells of a 96-well plate, and binding of
125I-V-(1-266) was measured in the presence of 0-5
µM unlabeled V-(1-266).
|
|
To establish that the changes in binding affinity induced by the DEPC
treatment resulted from His-906 modification, the H906A mutant was
treated with DEPC. This modified protein was then tested for its
ability to compete with V-(877-1066) for binding to V-(1-266). The
Ki values for the competition of V-(877-1066),
V-(877-1066/H906A), and the DEPC-modified V-(877-1066/H906A) in this
assay were 85 ± 20, 140 ± 35, and 115 ± 30 nM, respectively (data not shown). Thus the H906A mutation
protected the C-terminal domain from loss of binding affinity for
V-(1-266) by DEPC treatment.
The effect of the two single mutations and the double mutation on the
structure of the vinculin tail domain was studied using circular
dichroism (Fig. 3). At pH 7.0 there was
little difference between the measured circular dichroism spectra of
the histidine mutant and the unmutated V-(877-1066). At pH 5.5, however, the spectra showed measurable changes. In the wild type,
ellipticity at 208 nm was decreased at pH 5.5, causing the ratio
[
222]/[
208] to increase from 0.87 at
pH 7.0 to 1.07 at pH 5.5 (Fig. 3A). This change was also
observed for the H1026A mutant but not for V-(877-1066/H906A) (Fig. 3,
B and C). To define more precisely the pH
dependence of the conformational transition, circular dichroism spectra
were collected over a range of pH values. The conversion between
[
222]/[
208] < 1 to >1 occurs at pH
~6.5 (Fig. 4), which suggests that this conversion, like the conformational change in general, is reliant upon
the histidine residue. The H906A mutant showed no, or very little,
change, strongly supporting this idea.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Circular dichroism spectra of vinculin tail
histidine mutants at pH 7.0 and 5.5. Circular dichroism spectra
were collected using 2.5 µM V-(877-1066) (A),
V-(877-10966/H906A) (B), and V-(877-1066/H1026A)
(C). Spectra were collected from 200 to 260 nm at pH 7.0 (solid lines) and pH 5.5 (dotted lines).
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 4.
Change in the
[ ]208 and
[ ]222 of V-(877-1066) and
histidine mutants with pH. Circular dichroism spectra were
collected for V-(877-1066) (A), V-(877-1066/H906A)
(B), and V-(877-1066/H1026A) (C) between 200 and
260 nm. Spectra were collected over a pH range of 4.5-8.0. Data are
plotted as the [ ]208 ( ) and [ ]222
( ).
|
|
Gel Filtration Chromatography of V-(877-1066) and Histidine
Mutants--
To examine possible consequences of the conformational
changes seen at low pH, gel filtration profiles of V-(877-1066) and each of the histidine mutants were studied under different pH conditions (Fig. 5). V-(877-1066) was
found, at physiological pH, to elute with a molecular weight
(Mr) of ~25,000, which is the approximate
Mr of the monomeric species. However, upon
lowering the pH to 5.5, the eluting peak was shifted, indicating a
Mr of >100,000. Similar profiles were obtained
when examining V-(877-1066/H1026A) (Fig. 5C). The elution
profile of V-(877-1066/H906A), however, was much less affected by
acidic pH (Fig. 5B).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Gel filtration chromatography of
V-(877-1066) and histidine mutants at pH 7.0 and 5.5. Elution
profiles of V-(877-1066) (A), V-(877-1066/H906A)
(B), and V-(877-1066/H1026A) (C) at pH 7.0 ( )
and at pH 5.5 ( ). Data are presented as the percentage of total
protein that eluted from the column as measured by densitometry of
fractions run on SDS-polyacrylamide gel electrophoresis. Standards used
to calibrate the column are indicated (IgG, 160 kDa; bovine serum
albumin, 66.2 kDa; -lactoglobulin, 35 kDa; and cytochrome
c, 12.4 kDa).
|
|
Effect of Histidine Mutations on Lipid Inhibition of Head-Tail
Binding--
It is evident that both activity and conformational
changes induced by lowered pH were abrogated by mutation of histidine 906 to a nonionizable residue. To test the possibility that this residue may also affect the activity and conformational changes induced
by vinculin ligands, phospholipid was tested for its ability to alter
the conformation and activity of V-(877-1066/H906A).
Using a gel filtration-based lipid-binding assay, V-(877-1066/H906A)
was found to interact with PI vesicles (Fig.
6), like the wild type domain. Sixty-six
percent of the mutant co-eluted with lipid, compared with 63% of the
wild type. Despite this similarity in binding, the H906A mutant did not
undergo lipid-induced changes in its circular dichroism spectrum (Fig.
7). Circular dichroism of both the wild
type (not shown) and H1026A mutant (Fig. 7) showed a roughly 20%
decrease in the absolute value of the ellipticity in the 208-222 nm
range in the presence of 100 µM PI. In contrast, the
H906A spectrum remained unaltered in the presence of the lipid. These
spectral changes were different from those seen at low pH (Fig. 3), but
they still depended on the presence of histidine 906.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Phospholipid binding of
V-(877-1066/H906A). Elution profiles of 125I-labeled
V-(877-1066/H906A) (50 ng) in the presence ( ) or absence ( ) of
PI vesicles. The elution volume of PI vesicles was determined using a
detergent solubilization assay and is presented as the percent of total
PI measured eluting from the column ( ).
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Circular dichroism of histidine mutants in
the presence and absence of lipid. Circular dichroism spectra of
V-(877-1066/H906A) (A) and V-(877-1066/H1026A)
(B) were collected without lipid (solid lines) or
in the presence of 100 µM PI (dotted lines).
Spectra were collected from 200-260 nm at a protein concentration of
2.5 µM.
|
|
Because acidic lipids, notably PI and PIP2, inhibit N-C
interactions, it was of interest to determine whether the interaction between the H906A mutant and V-(1-266) would be similarly affected. A
range of concentrations of PI was included in an N-C binding assay
(Fig. 8). Although lipid could interfere
with H906A-N-terminal interactions, 5-10-fold higher concentrations
were required. The Ki of PI inhibition was
determined to be 104 ± 1.5 µM, in contrast to the
Ki of 17 ± 1.4 µM determined for
the PI inhibition for V-(1-266) binding to wild type
V-(877-1066).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of PI on N-terminal to C-terminal
binding. Each well of a 96-well plate was coated with
V-(877-1066) ( ) or V-(877-1066/H906A) ( ). The binding of
125I-labeled V-(1-266) was measured in the presence of
0-1 mM PI vesicles. Data are presented as the percentage
of V-(1-266) bound in the absence of PI. Each point is the mean ± S.D. of three experiments.
|
|
 |
DISCUSSION |
Efforts to purify the tightly associated N- and C-terminal domains
of vinculin after proteolytic cleavage of native vinculin first led to
the application of low pH (pH 5.0) to separate the domains (23). Later
work made it clear that the N-C interaction is a major regulatory
mechanism and controls the binding activities of the molecule (12).
Inside cells, the lipid PIP2 is likely the factor that
causes dissociation of the two domains (15, 16), but the mechanism has
not been studied. One possibility would be a simple competition for
binding to the C-terminal domain between the N-terminal and the lipid;
however, different conformations of the C-terminal have been detected
by limited proteolysis suggesting more complicated pathways. Several
factors pointed to histidines as possible key residues, and our
experiments reported here have amply confirmed their importance.
Our initial experiments showed that DEPC, a specific modifier of
histidine residues in proteins (32), inhibited the N-C interaction by
modifying residues in the C-terminal. This limited the possible targets
to two histidines at positions 906 and 1026. These residues are located
in quite different regions of the C-terminal crystal structure (Fig.
9). Because we had mapped the binding site for the N-terminal domain to residues 1009-1036 (17), we anticipated that His-1026 would be a target and used mutagenesis to
alanine to test this idea. Surprisingly, neither the H906A nor the
H1026A mutant showed defects in binding to the N-terminal at neutral
pH, raising the possibility that DEPC was reacting with some
other residue. To clarify the situation, DEPC treatment of the
mutants was performed, and this showed that His-906 was indeed the
important target. Thus, DEPC modification of histidine 906 inhibited binding to the N-terminal domain whereas a different modification (to alanine) did not. Possibly the increase in size of the
histidine side chain resulting from chemical modification changed the
structure enough to prevent binding. In support of this idea, the
circular dichroism spectra indicate a somewhat different conformation
after treatment. When a smaller side chain was substituted, no such
conformational distortion occurred, and binding to the N-terminal
domain could take place. One possibility is that electronic repulsion
between the protonated histidine and other nearby positively charged
residues may be a driving force for conformational change that is
mimicked by the steric repulsion due to the larger size of the
histidine side chain after DEPC treatment.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 9.
Basic environment of histidine 906. A
ribbon diagram of the structure of the vinculin C-terminal
tail domain from the crystal structure (19). The positions of specific
residues are marked.
|
|
To look for a possible role of this histidine in conformational
dynamics we examined the effects of pH on normal and mutant C-terminal
domains. Circular dichroism spectra showed clear evidence of changes.
There was little change in the 222 nm region that reflects the amount
of
-helix in the protein. Rather, ellipticity is decreased at 208 nm, changing the 208/222 ratio, often taken to indicate a rearrangement
of
-helices (33). Interestingly, one consequence of the change in
conformation is a shift to a larger apparent size by gel filtration,
probably corresponding to an oligomerization although a change in the
shape of the molecule could contribute to it. Oligomerization of the
C-terminal in the presence of phospholipids has been detected by
cross-linking, and specific regions prone to oligomerization have been
identified. One possibility is that the molecule "opens up" as
postulated by Bakolitsa et al. (19) to expose its more
hydrophobic interior that could then interact to form oligomers.
Structural determination of the low pH-induced conformation will be
needed to answer this question.
Because the H906A mutant no longer undergoes conformational changes at
low pH, protonation of His-906 in the wild type must be a key step, and
the charged side chain then results in changes in the binding site for
the N-terminal, some distance away in the molecule. The environment of
His-906 in the crystal structure gives few obvious clues to a mechanism
for this effect. The histidine is found in a basic region including
arginines 903 and 910 and lysine 924 (Fig. 9). Phenylalanine 885 and
aspartate 907 are also close neighbors. One interesting feature of the
crystal structure is the presence of a sulfate ion in a pocket formed
by His-906, Arg-910, and Lys-1061. This ion is likely a substitute for
the natural ligand, possibly a phosphate or a carboxyl group. The area
could provide a binding surface for negatively charged lipids. Nearby
negative charge would also be expected to increase the pK of
the histidine from the value of 6.0 for the free amino acid, possibly
explaining the pH of 6.5 for the conformational change. Protonation of
the histidine in a positively charged environment could lead to
electrostatic strain that triggers shifts in the relative position of
the helices.
The reduced sensitivity of the H906A mutant to binding inhibition by
PIP2 indicates that the histidine plays a role in
phospholipid effects as well. Because binding to PIP2 by
the mutant is normal, loss of the initial interaction is not an
explanation. The lack of change in the circular dichroism spectrum of
the mutant compared with the wild type protein in the presence of
PIP2 suggests that a requisite conformational change does
not occur in the mutant. The characteristics of the lipid-induced
change in circular dichroism seen in the wild type C-terminal are
different from those induced by low pH. Thus His-906 appears to be
important for two different conformational changes. There is some
evidence that the vinculin C-terminal also has a different conformation
when bound to actin (18, 19). It will be of interest to determine
whether the H906A mutation affects that interaction as well.
Reduction of pH has been reported to mimic the effect of phospholipid
binding to other proteins. In particular, apolipoprotein E (apoE)
undergoes conformational changes at low pH analogous to those that
occur upon its interaction with phospholipid (34). This example may be
of particular relevance as the N-terminal portion of apoE is
structurally similar to the vinculin C-terminal (19). The helices of
the apoE four-helix bundle are believed to reorient, resulting in an
extended conformation with increased phospholipid binding and insertion
activity, and a parallel model has been proposed for vinculin. There
are, however, no histidines in this region of apoE comparable with
histidine 906 in vinculin so the mechanism must be different. Lower pH
may affect a variety of interhelix interactions and, in apoE, allow
expression of conformational flexibility. In fact, it has been proposed
that the negatively charged, polar head groups on acidic lipids
increase the electrical surface potential in membranes, which leads to
a decrease in the surface pH (35). Thus a decrease in pH will have
similar effects on lipid binding for some proteins, with similar
intramolecular mechanisms. Further experiments will be needed to see if
this idea is applicable here, although the different circular dichroism spectra of lipid-bound versus low pH C-terminal suggests
that the conformations are different.
In summary, it is clear that His-906 plays a key role in the
conformational changes of the vinculin C-terminal domain. In turn, the
overall conformation and activity of vinculin is controlled by these
changes. Thus the H906A mutant will likely be useful in examining how
the protein functions and how it is regulated in its natural environment.
 |
ACKNOWLEDGEMENTS |
We thank Matthew Revington for his
technical assistance with the circular dichroism studies. The circular
dichroism studies were carried out using instrumentation in the
Biomolecular Interactions and Conformations Facility at the University
of Western Ontario.
 |
FOOTNOTES |
*
This work was supported by Grant MT13349 from the Medical
Research Council of Canada.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 519-661-3068;
Fax: 519-661-3175; E-mail: ehball@uwo.ca.
Published, JBC Papers in Press, May 29, 2001, DOI 10.1074/jbc.M102561200
 |
ABBREVIATIONS |
The abbreviations used are:
PIP2, phosphatidylinositol 4,5-bisphosphate;
DEPC, diethylpyrocarbonate;
PI, phosphatidylinositol;
MES, 4-morpholineethanesulfonic acid;
apoE, apolipoprotein E.
 |
REFERENCES |
| 1.
|
Geiger, B.,
Volk, T.,
and Volberg, T.
(1985)
J. Cell Biol.
101,
1523-1531
|
| 2.
|
Xu, W.,
Baribault, H.,
and Adamson, E. D.
(1998)
Development
125,
327-337
|
| 3.
|
Barstead, R. J.,
and Waterston, R. H.
(1989)
J. Biol. Chem.
264,
10177-10185
|
| 4.
|
Otto, J. J.
(1990)
Cell Motil. Cytoskeleton
16,
1-6
|
| 5.
|
Critchley, D. R.
(2000)
Curr. Opin. Cell Biol.
12,
133-139
|
| 6.
|
Jockusch, B. M.,
and Rudiger, M.
(1996)
Trends Cell Biol.
6,
311-315
|
| 7.
|
Goldmann, W. H.,
Ezzell, R. M.,
Adamson, E. D.,
Niggli, V.,
and Isenberg, G.
(1996)
J. Muscle Res. Cell Motil.
17,
1-5
|
| 8.
|
Rudiger, M.
(1998)
BioEssays
20,
733-740
|
| 9.
|
Schlessinger, J.,
and Geiger, B.
(1983)
Cell Motil. Cytoskel.
3,
399-403
|
| 10.
|
Ball, E.,
Freitag, C.,
and Gurofsky, S.
(1986)
J. Cell Biol.
103,
641-648
|
| 11.
|
Johnson, R. P.,
and Craig, S. W.
(1994)
J. Biol. Chem.
269,
12611-12619
|
| 12.
|
Johnson, R. P.,
and Craig, S. W.
(1995)
Nature
373,
261-264
|
| 13.
|
Kroemker, M.,
Rudiger, A. H.,
Jockusch, B. M.,
and Rudiger, M.
(1994)
FEBS Lett.
355,
259-262
|
| 14.
|
Huttelmaier, S.,
Mayboroda, O.,
Harbeck, B.,
Jarchau, T.,
Jockusch, B. M.,
and Rudiger, M.
(1998)
Curr. Biol.
8,
479-488
|
| 15.
|
Weekes, J.,
Barry, S. T.,
and Critchley, D. R.
(1996)
Biochem. J.
314,
827-832
|
| 16.
|
Gilmore, A. P.,
and Burridge, K.
(1996)
Nature
381,
531-535
|
| 17.
|
Miller, G. J.,
Dunn, S. D.,
and Ball, E. H.
(2001)
J. Biol. Chem.
276,
11729-11734
|
| 18.
|
Johnson, R. P.,
and Craig, S. W.
(2000)
J. Biol. Chem.
275,
95-105
|
| 19.
|
Bakolitsa, C.,
de Pereda, J. M.,
Bagshaw, C. R.,
Critchley, D. R.,
and Liddington, R. C.
(1999)
Cell
99,
603-613
|
| 20.
|
Johnson, R. P.,
and Craig, S. W.
(1995)
Biochem. Biophys. Res. Commun.
210,
159-164
|
| 21.
|
Tempel, M.,
Goldmann, W. H.,
Isenberg, G.,
and Sackmann, E.
(1995)
Biophys. J.
69,
228-241
|
| 22.
|
Johnson, R. P.,
Niggli, V.,
Durrer, P.,
and Craig, S. W.
(1998)
Biochemistry
37,
10211-10222
|
| 23.
|
Groesch, M. E.,
and Otto, J. J.
(1990)
Cell Motil. Cytoskeleton
15,
41-50
|
| 24.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 25.
|
Sarkar, G.,
and Sommer, S. S.
(1990)
BioTechniques
8,
404-407
|
| 26.
|
Guan, K. L.,
and Dixon, J. E.
(1991)
Anal. Biochem.
192,
262-267
|
| 27.
|
Rai, S. S.,
and Wolff, J.
(1998)
J. Biol. Chem.
273,
31131-31137
|
| 28.
|
Bohm, G.,
Muhr, R.,
and Jaenicke, R.
(1992)
Protein Eng.
5,
191-195
|
| 29.
|
Cheng, Y.,
and Prusoff, W. H.
(1973)
Biochem. Pharmacol.
22,
3099-3108
|
| 30.
|
Judd, R. C.
(1990)
Methods Enzymol.
182,
613-626
|
| 31.
|
Almog, R.,
Anderson-Samsonoff, C.,
Berns, D. S.,
and Saulsbery, R.
(1990)
Anal. Biochem.
188,
237-242
|
| 32.
|
Miles, E. W.
(1977)
Methods Enzymol.
47,
431-442
|
| 33.
|
Steinmetz, M. O.,
Stock, A.,
Schulthess, T.,
Landwehr, R.,
Lustig, A.,
Faix, J.,
Gerisch, G.,
Aebi, U.,
and Kammerer, R. A.
(1998)
EMBO J.
17,
1883-1891
|
| 34.
|
Clement-Collin, V.,
Leroy, A.,
Monteilhet, C.,
and Aggerbeck, L. P.
(1999)
Eur. J. Biochem.
264,
358-368
|
| 35.
|
van der Goot, F.,
Gonzalez-Manas, J.,
Lakey, J.,
and Pattus, F.
(1991)
Nature
354,
408-410
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L.-X. Weng, J.-L. Xu, Q. Li, R. G. Birch, and L.-H. Zhang
Identification of the essential histidine residue for high-affinity binding of AlbA protein to albicidin antibiotics
Microbiology,
February 1, 2003;
149(2):
451 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.